Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SOLARA.NS Stock Summary
In the News
SOLARA.NS Financial details
Company Rating
Strong Buy
Market Cap
11.97B
Income
-324.9M
Revenue
15.53B
Book val./share
406.79
Cash/share
5.83
Dividend
-
Dividend %
-
Employees
2.36K
Optionable
No
Shortable
Yes
Earnings
23 Jan 2024
P/E
-36.81
Forward P/E
46.17
PEG
8.33
P/S
0.77
P/B
0.82
P/C
57.02
P/FCF
23930.34
Quick Ratio
0.5
Current Ratio
1.03
Debt / Equity
0.67
LT Debt / Equity
0.13
-
-
EPS (TTM)
-9.03
EPS next Y
7.2
EPS next Q
-
EPS this Y
-61.93%
EPS next Y
-179.73%
EPS next 5Y
-363.57%
EPS last 5Y
NAN%
Revenue last 5Y
1.78%
Revenue Q/Q
20.7%
EPS Q/Q
-12.15%
-
-
-
-
SMA20
2.32%
SMA50
-6.42%
SMA100
-12.11%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-4%
ROC
0.03%
Gross Margin
46%
Oper. Margin
4%
Profit Margin
-2%
Payout
-
Shs Outstand
36M
Shs Float
15.2M
-
-
-
-
Target Price
-
52W Range
286.0-495.0
52W High
-32.85%
52W Low
+16.22%
RSI
47.29
Rel Volume
0.28
Avg Volume
134.03K
Volume
37.58K
Perf Week
-0.64%
Perf Month
9.56%
Perf Quarter
-13.1%
Perf Half Y
-6.14%
-
-
-
-
Beta
0.946
-
-
Volatility
2.45%, 11.37%
Prev Close
-0.6%
Price
332.4
Change
-1.35%
SOLARA.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 535.49 | 489.84 | 491.07 | 342.4 | 401.17 | |
Net income per share | 24.11 | 44.29 | 69 | -16.18 | -6.16 | |
Operating cash flow per share | 64.75 | 94.37 | 48.45 | -67.34 | 43.41 | |
Free cash flow per share | 43.47 | -9.53 | -5.93 | -125.39 | 12.49 | |
Cash per share | 2.51 | 27.53 | 70.53 | 15.8 | 6.15 | |
Book value per share | 387.16 | 419.62 | 495.06 | 424.29 | 416.84 | |
Tangible book value per share | 202.01 | 244.55 | 357.67 | 304.44 | 300.92 | |
Share holders equity per share | 387.16 | 419.62 | 495.06 | 424.29 | 416.84 | |
Interest debt per share | 247.55 | 305.14 | 218.45 | 307.36 | 306.45 | |
Market cap | 11.08B | 11.5B | 44.7B | 23.94B | 11.79B | |
Enterprise value | 15.7B | 18.16B | 48.93B | 33.85B | 21.83B | |
P/E ratio | 18.61 | 10.04 | 20.19 | -41.17 | -53.16 | |
Price to sales ratio | 0.84 | 0.91 | 2.84 | 1.95 | 0.82 | |
POCF ratio | 6.93 | 4.71 | 28.76 | -9.89 | 7.54 | |
PFCF ratio | 10.32 | -46.67 | -235.03 | -5.31 | 26.22 | |
P/B Ratio | 1.16 | 1.06 | 2.81 | 1.57 | 0.79 | |
PTB ratio | 1.16 | 1.06 | 2.81 | 1.57 | 0.79 | |
EV to sales | 1.19 | 1.43 | 3.11 | 2.75 | 1.51 | |
Enterprise value over EBITDA | 6.99 | 6.72 | 11.99 | 32.36 | 13.95 | |
EV to operating cash flow | 9.82 | 7.44 | 31.48 | -13.99 | 13.97 | |
EV to free cash flow | 14.63 | -73.69 | -257.27 | -7.51 | 48.57 | |
Earnings yield | 0.05 | 0.1 | 0.05 | -0.02 | -0.02 | |
Free cash flow yield | 0.1 | -0.02 | 0 | -0.19 | 0.04 | |
Debt to equity | 0.56 | 0.66 | 0.39 | 0.68 | 0.68 | |
Debt to assets | 0.27 | 0.34 | 0.24 | 0.35 | 0.35 | |
Net debt to EBITDA | 2.06 | 2.46 | 1.04 | 9.47 | 6.42 | |
Current ratio | 1 | 0.92 | 1.34 | 1.16 | 1.08 | |
Interest coverage | 2.07 | 2.56 | 3.55 | -0.39 | 0.31 | |
Income quality | 2.77 | 2.13 | 0.7 | 2.66 | -3.49 | |
Dividend Yield | 0 | 0.01 | 0 | 0 | 0 | |
Payout ratio | 0 | 0.11 | 0.09 | -0.19 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.02 | 0.03 | 0.16 | |
Research and developement to revenue | 0 | 0.05 | 0.04 | 0.05 | 0.03 | |
Intangibles to total assets | 0.24 | 0.21 | 0.17 | 0.15 | 0.14 | |
Capex to operating cash flow | -0.33 | -1.1 | -1.12 | 0.86 | -0.71 | |
Capex to revenue | -0.04 | -0.21 | -0.11 | -0.17 | -0.08 | |
Capex to depreciation | -0.63 | -2.86 | -1.61 | -1.86 | -1 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 458.29 | 646.64 | 876.68 | 393.02 | 240.36 | |
ROIC | 0.1 | 0.09 | 0.13 | -0.01 | 0.01 | |
Return on tangible assets | 0.04 | 0.07 | 0.1 | -0.02 | -0.01 | |
Graham Net | -248.97 | -243.84 | -69.59 | -185.61 | -185.67 | |
Working capital | -9.42M | -579M | 2.69B | 1.68B | 864.2M | |
Tangible asset value | 4.99B | 6.33B | 11.48B | 10.94B | 10.83B | |
Net current asset value | -3.45B | -3.91B | 368.1M | -1.86B | -2.09B | |
Invested capital | 0.56 | 0.66 | 0.39 | 0.68 | 0.68 | |
Average receivables | 1.79B | 3.27B | 4.3B | 5.58B | 5.61B | |
Average payables | 2.79B | 2.3B | 2.63B | 2.96B | 2.95B | |
Average inventory | 2.04B | 2.5B | 2.87B | 4.35B | 5.67B | |
Days sales outstanding | 98.91 | 84.89 | 130.87 | 163.63 | 144 | |
Days payables outstanding | 119.45 | 123.12 | 146.7 | 148.32 | 141.53 | |
Days of inventory on hand | 107.73 | 159.35 | 139.9 | 301.06 | 258.24 | |
Receivables turnover | 3.69 | 4.3 | 2.79 | 2.23 | 2.53 | |
Payables turnover | 3.06 | 2.96 | 2.49 | 2.46 | 2.58 | |
Inventory turnover | 3.39 | 2.29 | 2.61 | 1.21 | 1.41 | |
ROE | 0.06 | 0.11 | 0.14 | -0.04 | -0.01 | |
Capex per share | -21.28 | -103.9 | -54.38 | -58.05 | -30.93 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 94.1 | 105.27 | 105.65 | 97.85 | 118.2 | |
Net income per share | -2.77 | 0.12 | 1.05 | -5.43 | -4.77 | |
Operating cash flow per share | 0 | 0 | 0.01 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0.01 | 0 | 0 | |
Cash per share | 2.66 | 0 | 6.14 | 0 | 5.83 | |
Book value per share | 416.72 | 0 | 416.41 | 0 | 406.79 | |
Tangible book value per share | 298.63 | 0 | 300.61 | 0 | 292.45 | |
Share holders equity per share | 416.72 | 0 | 416.41 | 0 | 406.79 | |
Interest debt per share | 276.76 | 6.3 | 287.23 | 6.84 | 280.55 | |
Market cap | 14.98B | 16.13B | 11.8B | 13.73B | 12.85B | |
Enterprise value | 24.68B | 16.13B | 21.84B | 13.73B | 22.63B | |
P/E ratio | -37.6 | 896.25 | 78.23 | -17.56 | -18.72 | |
Price to sales ratio | 4.43 | 4.09 | 3.1 | 3.9 | 3.02 | |
POCF ratio | 0 | 0 | 23.59K | 0 | 0 | |
PFCF ratio | 0 | 0 | 23.59K | 0 | 0 | |
P/B Ratio | 1 | 0 | 0.79 | 0 | 0.88 | |
PTB ratio | 1 | 0 | 0.79 | 0 | 0.88 | |
EV to sales | 7.29 | 4.09 | 5.74 | 3.9 | 5.32 | |
Enterprise value over EBITDA | 78.88 | 30.92 | 40.86 | 64.9 | 58.32 | |
EV to operating cash flow | 0 | 0 | 43.68K | 0 | 0 | |
EV to free cash flow | 0 | 0 | 43.68K | 0 | 0 | |
Earnings yield | -0.01 | 0 | 0 | -0.01 | -0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.65 | 0 | 0.68 | 0 | 0.67 | |
Debt to assets | 0.34 | 0 | 0.35 | 0 | 0.34 | |
Net debt to EBITDA | 31 | 0 | 18.79 | 0 | 25.21 | |
Current ratio | 1.06 | 0 | 1.08 | 0 | 1.03 | |
Interest coverage | 0.12 | 1.02 | 1.23 | -0.28 | 0.52 | |
Income quality | 0 | 0 | 0.01 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0.03 | 0 | |
Intangibles to total assets | 0.15 | 0 | 0.14 | 0 | 0.14 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 161.16 | 0 | 99.02 | 0 | 208.95 | |
ROIC | 0 | 0 | 0.01 | 0 | 0.01 | |
Return on tangible assets | 0 | 0 | 0 | 0 | -0.01 | |
Graham Net | -200.56 | 0 | -185.48 | 0 | -191.55 | |
Working capital | 625.6M | 32.4M | 864.2M | 88.9M | 295.7M | |
Tangible asset value | 10.74B | 0 | 10.83B | 0 | 10.52B | |
Net current asset value | -2.3B | 32.4M | -2.09B | 88.9M | -2.14B | |
Invested capital | 0.65 | 0 | 0.68 | 0 | 0.67 | |
Average receivables | 2.4B | 2.4B | 2.85B | 2.85B | 2.8B | |
Average payables | 1.44B | 1.44B | 1.53B | 1.53B | 1.74B | |
Average inventory | 2.74B | 2.74B | 2.79B | 2.79B | 2.78B | |
Days sales outstanding | 127.88 | 0 | 134.69 | 0 | 118.69 | |
Days payables outstanding | 136.9 | 0 | 143.05 | 0 | 131.86 | |
Days of inventory on hand | 260.49 | 0 | 261.02 | 0 | 211 | |
Receivables turnover | 0.7 | 0 | 0.67 | 0 | 0.76 | |
Payables turnover | 0.66 | 0 | 0.63 | 0 | 0.68 | |
Inventory turnover | 0.35 | 0 | 0.34 | 0 | 0.43 | |
ROE | -0.01 | 0 | 0 | 0 | -0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SOLARA.NS Frequently Asked Questions
What is Solara Active Pharma Sciences Limited stock symbol ?
Solara Active Pharma Sciences Limited is a IN stock and trading under the symbol SOLARA.NS
What is Solara Active Pharma Sciences Limited stock quote today ?
Solara Active Pharma Sciences Limited stock price is $332.4 today.
Is Solara Active Pharma Sciences Limited stock public?
Yes, Solara Active Pharma Sciences Limited is a publicly traded company.